Ms. Jodie Lynn Morris, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 Curry Rd, Waynesburg, PA 15370 Phone: 724-852-6229 Fax: 724-852-6229 |
Mrs. Megan Leigh Morrell, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Center Ave, Waynesburg, PA 15370 Phone: 724-852-2020 |
Nicole Renae Keffer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 265 Elm Dr, Waynesburg, PA 15370 Phone: 724-627-0685 Fax: 724-627-0849 |
Emily Michelle Spade, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 160 Greene Plz, Rts 21 & 79, Waynesburg, PA 15370 Phone: 724-852-2504 Fax: 724-852-2547 |
Jennifer Christine Gregor, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 160 Greene Plz, Rts 21 And 79, Waynesburg, PA 15370 Phone: 724-852-2504 Fax: 724-852-2547 |
James Andrew Jefferson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 222 Elm Dr, Waynesburg, PA 15370 Phone: 412-833-6663 Fax: 412-833-1458 |
Arianne Ward, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 Curry Rd, Waynesburg, PA 15370 Phone: 724-833-9742 Fax: 724-833-9449 |
Erin Virgili, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 122 Blaker Ridge Rd, Waynesburg, PA 15370 Phone: 724-986-6686 |
Miss Jaimie T Miller, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 385 Nazer St, Waynesburg, PA 15370 Phone: 301-938-1331 |
Alissa Joy Fox Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1078 8th St, Waynesburg, PA 15370 Phone: 724-986-8742 |
Brianne Hanlon, SPEECH THERAPIST Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 160 Greene Plz # Rts2179, Waynesburg, PA 15370 Phone: 724-852-2504 Fax: 724-852-2547 |
Mrs. Lisa Marie Soltys Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Center Ave, Waynesburg, PA 15370 Phone: 724-852-2020 |
Miss Liza Baldini, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Bill George Dr, Waynesburg, PA 15370 Phone: 724-627-3441 |
Georgetta Mckenzie Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Center Ave, Waynesburg, PA 15370 Phone: 724-852-2020 |
Dina Alexander, SPEECH THERAPIST Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 265 Elm Dr, Waynesburg, PA 15370 Phone: 724-627-0685 Fax: 724-627-0849 |
Mrs. Kelly Suzanne Kiger, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Bill George Dr, Waynesburg, PA 15370 Phone: 724-627-3441 |
Rachel Buettner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 265 Elm St, Waynesburg, PA 15370 Phone: 724-852-2504 Fax: 724-852-2547 |
Jamie Nicole Bate Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Bill George Dr, Waynesburg, PA 15370 Phone: 724-627-3441 |
Advanced Speech Therapy Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 Bonar Ave, Waynesburg, PA 15370 Phone: 724-627-2632 Fax: 724-627-3712 |
Megan Kara Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Center Ave, Waynesburg, PA 15370 Phone: 724-852-2020 |
News Archive
The U.S. Food and Drug Administration (FDA) has sent a warning letter to Procter & Gamble for making unlawful claims about its Vicks Early Defense Foaming Hand Sanitizer (Early Defense) product.
New research from BYU's autism experts is providing clues into the link between aggression and autism - clues the team hopes will eventually lead to more effective intervention.
Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team led by scientists at the Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes), led by Aleksander Edelman, has recently discovered two new compounds that could be used to treat patients carrying the most common mutation.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
› Verified 6 days ago